Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - NetShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sanofi (SNY) Other Non-Current Assets (2016 - 2024)

Historic Other Non-Current Assets for Sanofi (SNY) over the last 15 years, with Q3 2025 value amounting to $161.3 million.

  • Sanofi's Other Non-Current Assets changed N/A to $161.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $161.3 million, marking a year-over-year change of. This contributed to the annual value of $14.4 billion for FY2024, which is 31408.84% up from last year.
  • Latest data reveals that Sanofi reported Other Non-Current Assets of $161.3 million as of Q3 2025.
  • In the past 5 years, Sanofi's Other Non-Current Assets registered a high of $14.4 billion during Q1 2025, and its lowest value of $161.3 million during Q3 2025.
  • Its 5-year average for Other Non-Current Assets is $5.2 billion, with a median of $3.5 billion in 2022.
  • Per our database at Business Quant, Sanofi's Other Non-Current Assets tumbled by 1172.8% in 2022 and then soared by 31631.2% in 2024.
  • Over the past 5 years, Sanofi's Other Non-Current Assets (Quarter) stood at $3.6 billion in 2021, then fell by 11.73% to $3.2 billion in 2022, then rose by 9.65% to $3.5 billion in 2023, then soared by 316.31% to $14.4 billion in 2024, then plummeted by 98.88% to $161.3 million in 2025.
  • Its Other Non-Current Assets was $161.3 million in Q3 2025, compared to $4.7 billion in Q2 2025 and $14.4 billion in Q1 2025.